Page last updated: 2024-09-04

valerylsalicylate and ng-nitroarginine methyl ester

valerylsalicylate has been researched along with ng-nitroarginine methyl ester in 1 studies

Compound Research Comparison

Studies
(valerylsalicylate)
Trials
(valerylsalicylate)
Recent Studies (post-2010)
(valerylsalicylate)
Studies
(ng-nitroarginine methyl ester)
Trials
(ng-nitroarginine methyl ester)
Recent Studies (post-2010) (ng-nitroarginine methyl ester)
240512,6401172,342

Protein Interaction Comparison

ProteinTaxonomyvalerylsalicylate (IC50)ng-nitroarginine methyl ester (IC50)
Neutrophil elastaseHomo sapiens (human)2.7
Nitric oxide synthase, endothelialHomo sapiens (human)2.1
Nitric oxide synthase, brainHomo sapiens (human)1.1167
Nitric oxide synthase, inducibleMus musculus (house mouse)2.6
Nitric oxide synthase, inducibleHomo sapiens (human)8
Collagenase 3Homo sapiens (human)2.7

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huang, A; Jacobson, A; Kaley, G; Liu, H; Ojaimi, C; Sun, D; Yan, C1

Other Studies

1 other study(ies) available for valerylsalicylate and ng-nitroarginine methyl ester

ArticleYear
COX-2 contributes to the maintenance of flow-induced dilation in arterioles of eNOS-knockout mice.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:3

    Topics: Animals; Arterioles; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Endothelium, Vascular; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Male; Membrane Proteins; Mice; Mice, Knockout; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitrobenzenes; Prostaglandins; Regional Blood Flow; Salicylates; Sulfonamides; Vasodilation

2006